Show simple item record

dc.contributor.authorEshetie, Setegn
dc.contributor.authorGizachew, Mucheye
dc.contributor.authorAlebel, Animut
dc.contributor.authorvan Soolingen, Dick
dc.date.accessioned2018-04-19T09:42:17Z
dc.date.available2018-04-19T09:42:17Z
dc.date.issued2018
dc.identifier.citationTuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: A systematic review and meta-analysis. 2018, 13 (3):e0194675 PLoS ONEen
dc.identifier.issn1932-6203
dc.identifier.pmid29554144
dc.identifier.doi10.1371/journal.pone.0194675
dc.identifier.urihttp://hdl.handle.net/10029/621799
dc.description.abstractKnowledge of tuberculosis (TB) treatment outcomes is substantially needed to assess the performance of national TB controls programs (NTPs). To date, the overall estimates of treatment outcomes have not been determined in Ethiopia. Therefore, this meta-analysis was undertaken to produce pooled estimates of TB treatment outcomes and to analyze the impact of prior anti-TB drug exposure and HIV co-infection.
dc.language.isoenen
dc.rightsArchived with thanks to PloS oneen
dc.titleTuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: A systematic review and meta-analysis.en
dc.typeArticleen
dc.identifier.journalPLoS One 2018; 13(3):e0194675en
html.description.abstractKnowledge of tuberculosis (TB) treatment outcomes is substantially needed to assess the performance of national TB controls programs (NTPs). To date, the overall estimates of treatment outcomes have not been determined in Ethiopia. Therefore, this meta-analysis was undertaken to produce pooled estimates of TB treatment outcomes and to analyze the impact of prior anti-TB drug exposure and HIV co-infection.


This item appears in the following Collection(s)

Show simple item record